Today: 20 March 2026
Browse Category

NYSE:UNH 10 January 2026 - 21 January 2026

UnitedHealth stock back in focus: Bernstein sticks with $444 target as UNH earnings near

UnitedHealth stock back in focus: Bernstein sticks with $444 target as UNH earnings near

UnitedHealth shares closed down 2.3% at $331.02 Friday as Bernstein reiterated an Outperform rating and $444 target, citing potential margin recovery in Medicare Advantage and Medicaid. The company reports earnings and 2026 guidance Jan. 27, with investors focused on medical costs and outlook. U.S. lawmakers will question UnitedHealth’s CEO Jan. 22 on coverage affordability. Markets reopen Tuesday after the holiday.
UnitedHealth stock slips into the holiday pause: what UNH investors watch before Jan. 27 guidance

UnitedHealth stock slips into the holiday pause: what UNH investors watch before Jan. 27 guidance

UnitedHealth shares dropped 2.3% to $331.02 Friday, leading healthcare declines before the Martin Luther King Jr. Day market closure. The company faces scrutiny after a Senate report accused it of inflating Medicare Advantage payments, which UnitedHealth denies. Investors await its 2025 results and 2026 guidance, due Jan. 27. A possible sale of Optum UK to TPG remains under negotiation.
18 January 2026
Why UnitedHealth stock fell today: UNH slides as Medicare Advantage spotlight returns

Why UnitedHealth stock fell today: UNH slides as Medicare Advantage spotlight returns

UnitedHealth shares fell 2.3% to $331.02 in after-hours trading Friday following a MedPAC report highlighting $76 billion in projected Medicare Advantage overpayments. The drop came ahead of a long holiday weekend and the company’s earnings release set for Jan. 27. Managed-care stocks broadly declined, with Humana down 3.76% and Elevance Health off 1.85%.
17 January 2026
UnitedHealth stock drops today — what traders are watching before UNH earnings

UnitedHealth stock drops today — what traders are watching before UNH earnings

UnitedHealth shares fell 1.3% to $334.40 Friday, weighing on the Dow as managed-care stocks slid after Trump’s new healthcare proposal. The plan, which would replace insurance subsidies with direct payments to consumers, left policy details unclear and insurers under pressure. UnitedHealth will report 2025 earnings and its 2026 outlook on Jan. 27. Investors are watching for updates on government-plan costs and future guidance.
Dow Jones Today: Dow slips as options expiry hits and investors weigh bank earnings

Dow Jones Today: Dow slips as options expiry hits and investors weigh bank earnings

The Dow Jones Industrial Average fell 70 points, or 0.14%, to 49,372.07 in early Friday trading as losses in healthcare and consumer stocks offset gains in tech. The S&P 500 edged up 0.07%, while the Nasdaq rose 0.26%. PNC Financial jumped 3.9% after reporting a 25% profit increase. Options expiration and muted volatility kept traders cautious near record highs.
UnitedHealth stock climbs as UnitedHealthcare rolls out fast-pay Medicare Advantage pilot for rural hospitals

UnitedHealth stock climbs as UnitedHealthcare rolls out fast-pay Medicare Advantage pilot for rural hospitals

UnitedHealth shares rose 1.2% to $338.96 after launching a six-month pilot to speed up Medicare Advantage payments to rural hospitals in four states. The initiative aims to cut collection times to under 15 days. Investors await UnitedHealth’s 2025 earnings and 2026 forecast, due Jan. 27. The company faces scrutiny after a Senate report accused it of aggressive coding practices, which UnitedHealth disputes.
16 January 2026
UnitedHealth stock rebounds as rural Medicare payment pilot rolls out, earnings next in focus

UnitedHealth stock rebounds as rural Medicare payment pilot rolls out, earnings next in focus

UnitedHealth shares rose 0.7% to $337.27 after rebounding from a 2% drop Thursday. The move followed UnitedHealthcare’s launch of a six-month pilot to speed Medicare Advantage payments for rural hospitals in four states. Investors are focused on the company’s Jan. 27 earnings and 2026 outlook. Rural providers face financial strains as federal budget changes loom.
UnitedHealth stock in focus after rural hospital payment pilot — and a Senate Medicare report

UnitedHealth stock in focus after rural hospital payment pilot — and a Senate Medicare report

UnitedHealth shares rose 0.3% to $334.96 in after-hours trading after its UnitedHealthcare unit launched a pilot to speed Medicare Advantage payments to rural hospitals. The move comes as a Senate committee report accuses UnitedHealth of inflating reimbursements through aggressive coding, which the company disputes. Investors await UnitedHealth’s 2026 outlook on Jan. 27.
15 January 2026
UnitedHealth stock jumps as insurer speeds Medicare Advantage payments for rural hospitals

UnitedHealth stock jumps as insurer speeds Medicare Advantage payments for rural hospitals

UnitedHealth Group shares rose 1.7% to $339.53 midday Wednesday after its UnitedHealthcare unit announced a pilot to speed Medicare Advantage payments to rural hospitals. The move follows a Senate report accusing UnitedHealth of aggressive billing, which the company disputes. Executives plan to reaffirm 2025 earnings targets in upcoming investor calls. Full-year 2025 results and 2026 outlook are due Jan. 27.
14 January 2026
Healthcare stocks face JPMorgan conference pressure as XLV slips and deal talk builds

Healthcare stocks face JPMorgan conference pressure as XLV slips and deal talk builds

U.S. healthcare stocks fell this week, with the XLV ETF down 0.5% to $157.31, even as the S&P 500 hit a record high. Two biotech firms, Eikon Therapeutics and Veradermics, filed for IPOs. Healthcare M&A value rose 56% in 2025 to $403 billion, despite fewer deals. Insmed reported preliminary 2025 ARIKAYCE sales of $433.8 million and set a 2026 revenue target of $450–470 million.
10 January 2026
UnitedHealth stock (UNH) hit by fresh Senate heat as nursing-home probe widens before earnings

UnitedHealth stock (UNH) hit by fresh Senate heat as nursing-home probe widens before earnings

UnitedHealth shares fell 0.8% to $343.98 Friday as senators widened their probe into the company’s nursing-home programs, citing unsatisfactory responses. Lawmakers warned they may escalate pressure if UnitedHealth does not cooperate. The company’s earnings call is set for Jan. 27. Investors are also awaiting the Jan. 13 consumer price index data.
1 2 3 4 5 6 9

Stock Market Today

  • RTX Shares See 52% Gain in Year - Is It Overvalued at $200?
    March 20, 2026, 1:45 AM EDT. RTX's share price rose 51.8% over the past year but dropped 1.4% last month, trading around $200.73. A Discounted Cash Flow (DCF) analysis values RTX at $183.11, suggesting the stock is about 9.6% overvalued based on projected free cash flows. Despite promising aerospace and defense sector positioning, valuation signals are mixed, with a 3 out of 6 score indicating both undervaluation and fair pricing factors. Investors should watch RTX closely for market shifts and updates to fundamentals that could affect its value.
Go toTop